Evidence map›Paper›PMID 21600203›Full record

ReviewFEBS letters2011

MicroRNAs in rheumatoid arthritis.

Angela Ceribelli, Md A Nahid, Minoru Satoh, Edward K L Chan

Open access · bronzeAbstract readReview
In one paragraph

Review in FEBS letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Expression and function analysis of microRNA in collagen-induced arthritis rats.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. miR-26a-5p Regulates Synovial Fibroblast Invasion in Patients with Rheumatoid Arthritis by Targeting Smad 1.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Angela CeribelliDepartment of Oral Biology, University of Florida, Gainesville, FL 32610-0424, USA. aceribelli@dental.ufl.edu
Md A Nahid
Minoru Satoh
Edward K L Chan
University of Florida · US

Funding

Novel Proteins Associated with SS-A/Ro in Target OrgansR01AI047859 · NIAID · UNIVERSITY OF FLORIDA · PI CHAN, EDWARD K · 2001 to 2011
$3.1M
NOVEL PROTEINS ASSOCIATED WITH SS-A/RO IN TARGET ORGANSR21AI047859 · NIAID · SCRIPPS RESEARCH INSTITUTE · PI CHAN, EDWARD K · 2000 to 2000
$310k
NIAID NIH HHS AI47859NIAID NIH HHS R01 AI047859NIAID NIH HHS R21 AI047859
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a chronic and severe autoimmune disease that affects joint tissues, bone, and cartilage. However, the pathogenesis of RA is still unclear. Autoantibodies such as rheumatoid factor and anti-cyclic citrullinated peptide are useful tools for early diagnosis, monitoring disease activity, and predicting prognosis. Recently, many groups have focused their attention on the role of microRNAs in the pathogenesis of RA, as well as a potential biomarker to monitor RA. In fact, the expression of some microRNAs, such as miR-146a, is upregulated in different cell types and tissues in RA patients. MicroRNAs in RA could also be considered as possible future targets for new therapeutic approaches.

Indexed as

AnimalsArthritis, RheumatoidHumansImmune SystemMicroRNAsModels, ImmunologicalMicroRNAs

Identifiers

PMID21600203
PMCPMC3168677
OpenAlexW2075810631

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.